Seeking Alpha

104192

104192
Send Message
View as an RSS Feed
View 104192's Comments BY TICKER:
Latest  |  Highest rated
  • Neostem: A Multi-Faceted Stem Cell Sector Play [View article]
    Neostem prices 5 mln share public offering at $7.00 per share.
    Oct 4, 2013. 04:04 PM | Likes Like |Link to Comment
  • Mazor Robotics And The Medical Revolution [View article]
    Medical supplier Stryker buys Mako Surgical in $1.65 billion transaction or $30 a share reported on 9/25/13.
    Sep 26, 2013. 09:55 PM | Likes Like |Link to Comment
  • Kandi Technologies: Is Kandi's Short Seller A Dead Man Walking? [View article]
    Thanks Arthur for this informative article which was very easy to understand in layman's terms. Unfortunately stock manipulation will not go away anytime soon. So we just have to do our DD and stand our ground and hold onto our stock. Have a safe and wonderful trip and come home with more information to share.
    Sep 20, 2013. 04:22 AM | Likes Like |Link to Comment
  • 10 Reasons Why Idera Pharmaceutical, Inc (IDRA) Will Bring Significant Return To Your Portfolio In Months. [View instapost]
    Thanks for sharing your trading idea, I will follow. Long $IDRA!
    Sep 20, 2013. 02:23 AM | Likes Like |Link to Comment
  • Gilead Sciences' Move Into Cancer Drugs [View article]
    @Peter Geschek, why write this article when you could've redirected to Bloomberg article dated 2/1/13 with the same information? You're not offering new insight on $GILD.
    May 27, 2013. 12:38 AM | 2 Likes Like |Link to Comment
  • Gilead Sciences' Move Into Cancer Drugs [View article]
    @Alancoit, price target was taken from Bloomberg article dated 2/1/13, like most information was taken from that article too.
    May 27, 2013. 12:34 AM | 1 Like Like |Link to Comment
  • Gilead Sciences' Move Into Cancer Drugs [View article]
    John Milligan is not the CEO of $GILD, he's the President and COO. John Martin is the Chairman and CEO of $GILD.
    May 26, 2013. 09:39 PM | 1 Like Like |Link to Comment
  • 1 Healthcare, 1 Basic Materials And 1 Tech Mid Cap With Recent Intensive Insider Selling [View article]
    So with all the insider selling, what's your analysis on $ISIS?
    May 12, 2013. 02:21 PM | Likes Like |Link to Comment
  • Intel: Busting Another False Myth [View article]
    @JJ: No problem.
    May 11, 2013. 11:18 PM | 1 Like Like |Link to Comment
  • Intel: Busting Another False Myth [View article]
    Because Ashraf does a great job explaining INTC.
    May 11, 2013. 11:07 PM | 1 Like Like |Link to Comment
  • Intel: Busting Another False Myth [View article]
    You should work for $INTC.
    May 11, 2013. 10:50 PM | Likes Like |Link to Comment
  • Celgene: Going Higher And Higher [View article]
    @AP: Thanks for sharing your long term experience on holding $CELG and I'd learned plenty from it. Any chance you'll be writing up an article on $GILD?
    May 6, 2013. 07:07 AM | 1 Like Like |Link to Comment
  • Intel: A Must-Read History Lesson [View article]
    @AE: You're no longer an $INTC fanboy, you've become $INTC fanman now. Good luck on your $INTC holdings and as always a nice article.
    May 5, 2013. 04:59 AM | 2 Likes Like |Link to Comment
  • The 3 Drivers Behind The Big Pharma Rally [View article]
    The acquisition of Inhibitex was a disaster, $BMY wrote off a $1.8b charge related to a failed hepatitis C drug.
    Apr 26, 2013. 12:55 AM | Likes Like |Link to Comment
  • Vertex Spikes On Phase II Data, Then The CFO Sells His Shares [View article]
    As a new investor,I would agree with your article and I wouldn't have the confidence investing in $VRTX now. The CFO should definitely know the true value of the company. He's taking most of his profits now after phase II results as opposed to waiting for final approvals and subsequent sales numbers in the future.
    Apr 24, 2013. 02:21 AM | Likes Like |Link to Comment
COMMENTS STATS
185 Comments
129 Likes